Generic Anastrozole - Arimidex

Latest News

• MDx/CDx Focus: NanoString Kicks off Second PAM50 Validation Study; MDxHealth ... - GenomeWeb
  

  MDx/CDx Focus: NanoString Kicks off Second PAM50 Validation Study; MDxHealth .

• NanoString Initiates Second Clinical Validation Study for Breast Cancer Assay - MarketWatch (press release)
  

  NanoString Initiates Second Clinical Validation Study for Breast Cancer AssayMarketWatch (press release)The ABCSG8 study, initiated in 1996, demonstrated that compared to treatment with tamoxifen alone, sequential adjuvant treatment with tamoxifen followed by anastrozole in postmenopausal women with hormone receptor-positive early-stage breast cancer .

• Increased Mammograms Up to 65% Responsible for Breast Cancer Mortality Reduction - MarketWatch (press release)
  

  Increased Mammograms Up to 65% Responsible for Breast Cancer Mortality ReductionMarketWatch (press release)Drugs covered include: Abiraterone acetate (Zytiga), Afatinib (Tomtovok), Afimoxifene (TamoGel), Albumin-bound paclitaxel (Abraxane), Anastrozole (Arimidex), Apatinib, Bevacizumab (Avastin), Bosutinib, Capecitabine (Xeloda), Cediranib, .

• NanoString Initiates Second Clinical Validation Study for Breast Cancer Assay - EON: Enhanced Online News (press release)
  

  NanoString Initiates Second Clinical Validation Study for Breast Cancer AssayEON: Enhanced Online News (press release)The ABCSG8 study, initiated in 1996, demonstrated that compared to treatment with tamoxifen alone, sequential adjuvant treatment with tamoxifen followed by anastrozole in postmenopausal women with hormone receptor-positive early-stage breast cancer .

• Norton Rose Group | Pharma in brief - Canada: Federal Court of Appeal upholds ... - Linex Legal (press release) (registration)
  

  Norton Rose Group | Pharma in brief - Canada: Federal Court of Appeal upholds .